Literature DB >> 3012831

Major cerebral infarction from tumor embolus.

N W Lefkovitz, U Roessmann, S H Kori.   

Abstract

A major right hemispheric infarct developed in a 31-year-old man within forty-eight hours of lung resection for metastatic synovial-cell sarcoma. Post mortem exam revealed tumorous occlusion of the right internal carotid artery. Major stroke from cerebral tumor embolus should be seriously considered in patients with primary or metastatic lung cancer who have had a very recent pneumonectomy, especially when there are symptoms and signs of multi-organ or extremity ischemia.

Entities:  

Mesh:

Year:  1986        PMID: 3012831     DOI: 10.1161/01.str.17.3.555

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  6 in total

1.  Brain tumor masquerading as stroke.

Authors:  L B Morgenstern; R F Frankowski
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

2.  Direct tumor embolism presenting as an acute ischemic stroke.

Authors:  Hernan Nicolas Lemus; Christine Lu; Hazem Shoirah; Tomoyoshi Shigematsu; John Liang; Tayler Van Denakker; Irene Boniece; Maryna Skliut
Journal:  Neurol Clin Pract       Date:  2019-12

3.  Incidence and etiology of cerebrovascular disease in patients with malignancy.

Authors:  Jeffrey M Katz; Alan Z Segal
Journal:  Curr Atheroscler Rep       Date:  2005-07       Impact factor: 5.967

4.  Ischemic Stroke in Critically Ill Patients with Malignancy.

Authors:  Jeong-Am Ryu; Oh Young Bang; Gee Young Suh; Jeong Hoon Yang; Daesang Lee; Jinkyeong Park; Joongbum Cho; Chi Ryang Chung; Chi-Min Park; Kyeongman Jeon
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

5.  Clinical Features and Prognostic Factors of Acute Ischemic Stroke Related to Malignant Gastrointestinal Tumor.

Authors:  Yating Liu; Xin Li; Feixue Song; Xin Yan; Zhijian Han; Futian Tang; Yumin Li
Journal:  Front Neurol       Date:  2021-11-25       Impact factor: 4.003

6.  D-dimer levels and cerebral infarction in critically ill cancer patients.

Authors:  Jeong-Am Ryu; Oh Young Bang; Geun-Ho Lee
Journal:  BMC Cancer       Date:  2017-08-30       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.